DENOS has the ambition to actively contribute to the development of top-level
personalized medicine, boosted by new technologies and digital innovations.
DENOS has the ambition to actively contribute to the development of top-level
personalized medicine, boosted by new technologies and digital innovations.
We are focused on three aspects of personalized medicine :
• Personalization of therapies and patients medical pathways.
• Personalization considering the human being in its globality, complexity, health determinants and environment.
• Personalization implying with the patient, mixing physical accompaniment and use of connected devices.
This spans across all geographical borders , in order to maximize the opportunity by bringing together national healthcare systems.
We are
specialized in
Our
commitments
Selection of the most
appropriate healthcare providers
Confidentiality and data protection
Follow-up during all the medical pathway
Commitment to find the best cost-effective price
Various working
languages
Access
24/7
Selection of the most
appropriate healthcare providers
Confidentiality
Follow-up during all the medical pathway
Commitment to find the best cost-effective price
Various working
languages
Availability
H24 7/7
Our
ecosystem
From a long tradition of French excellence in healthcare to international health
The French Healthcare System is considered to be one of the bests in the world. Indeed, in a World Health Organization comparison of 191 different countries, France came out at number one. Despite being expensive to maintain and under constant funding pressure, the French system offers a wide choice of general practitioners and healthcare specialists.
The French healthcare expertise with a worldwide outreach among this environment, DENOS is part of French Healthcare, an organization created to gather key actors of the healthcare system in France, whose approach intends to promote the French vision in terms of worldwide health, based on a humanist approach of healthcare and a right and fair access to healthcare products and services.
The challenges facing healthcare systems in intermediary developing countries are manifold: securing access to consultants and practitioners trained in advanced medical techniques, being able to lean on recognized therapy procedures and practices, and enabling patients suffering from complex pathologies to benefit from care in the world’s top hospitals.
The objective of DENOS Health Management is to meet the growing needs of public and private hospital facilities by providing teams of experts, consultants and experienced nursing staff and health practitioners, who will be able to respond in every sector of the functioning of hospitals.
As a result, the activities of DENOS Health Management cover recruitment and training of staff, implementation of nursing procedures, and day-to-day intendance of hospitals, handled by the company.
To do so, it falls back on expertise and procedures that are very much inspired by French hospital practices and nursing – the base of a healthcare system that the World Health Organization has acknowledged as being the world’s finest.
Therefore, DENOS Health Management is the first French company to position itself in the fast-growing sector of international hospital consulting (still largely dominated by Anglo-Saxon companies).
We created a new radiopharmaceutical biotech company, Zionexa, specialized in the development and commercialization of in-vivo biomarkers and targeted radiopharmaceutical therapies in oncology.
Zionexa is based in France and in the United-States, and actively works on developing its ambitious R&D pipeline of diagnostic radiotracers and targeted radiopharmaceutical therapies, to help clinicians adapt treatments to their patients, and thus improve their quality of life.
